NCT04365413: A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors

NCT04365413
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patient must be scheduled for surgical removal of the tumor & completed standard imaging prior to surgery
Exclusions: Patients with central nervous system tumors
https://ClinicalTrials.gov/show/NCT04365413

Comments are closed.

Up ↑